Intravenous itraconazole (ITRA) versus caspofungin (CASPO) for prophylaxis of invasive fungal infections (IFI) in patients (PTS) with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) undergoing induction chemotherapy (IC).

被引：0
|
作者：
Mattiuzzi, GN
Riehl, TD
Pierce, SR
Rex, JH
Cortes, JE
Giles, FJ
Garcia-Manero, G
Verstovsek, S
Malekshamran, K
Kantarjian, HM
Estey, EH
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Houston, TX 77030 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1286
引用
收藏
页码：332A / 332A
页数：1
相关论文
共 50 条
  • [1] Causes of pneumonia (pn) in patients (pts) with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) undergoing induction chemotherapy (IC).
    Mattiuzzi, G
    Pierce, S
    Faderl, S
    Cortes, J
    Koller, C
    Estey, E
    [J]. BLOOD, 2000, 96 (11) : 324A - 324A
  • [2] Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy
    Mattiuzzi, GN
    Kantarjian, H
    O'Brien, S
    Kontoyiannis, DP
    Giles, F
    Zhou, X
    Lim, J
    Bekele, BN
    Faderl, S
    Cortes, J
    Pierce, S
    Leitz, GJ
    Raad, I
    Estey, E
    [J]. CANCER, 2004, 100 (03) : 568 - 573
  • [3] Intravenous voriconazole (IV-VORI) prevents invasive fungal infections (IFI) in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
    Mattiuzzi, GN
    Alvarado, G
    Kantarjian, HM
    Verstovsek, S
    Cabanillas, M
    Faderl, S
    Lim, JT
    Giles, F
    Beran, M
    O'Brien, S
    Estey, EH
    [J]. BLOOD, 2004, 104 (11) : 253A - 253A
  • [4] Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction - Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
    Mattiuzzi, GN
    Estey, E
    Raad, I
    Giles, F
    Cortes, J
    Shen, Y
    Kontoyiannis, D
    Koller, C
    Munsell, M
    Beran, M
    Kantarjian, H
    [J]. CANCER, 2003, 97 (02) : 450 - 456
  • [5] Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
    Mattiuzzi, GN
    Kantarjian, H
    Faderl, S
    Lim, J
    Kontoyiannis, D
    Thomas, D
    Wierda, W
    Raad, I
    Garcia-Manero, G
    Zhou, M
    Ferrajoli, A
    Bekele, N
    Estey, E
    [J]. CANCER, 2004, 100 (03) : 581 - 589
  • [6] INTRAVENOUS ITRACONAZOLE FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN CHILDREN WITH ACUTE MYELOID LEUKEMIA AND RELAPSED ACUTE LEUKEMIA UNDERGOING INDUCTION CHEMOTHERAPY
    Lassaletta, Alvaro
    Adan, Rosa
    Gonzalez-Vicent, Marta
    Baro, Maria
    Perez-Martinez, Antonio
    Monteserin, M. C.
    Fuster, Jose-Luis
    Baragano, Marta
    Miranda, Isabel
    Madero, Luis
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 865 - 865
  • [7] Acute myelogenous leukemia (AML) type induction chemotherapy for the patients with myelodysplastic syndrome (MDS)
    Kim, D.-Y.
    Kim, J.-S.
    Kim, B.-S.
    Bang, S.-M.
    Kim, I.
    Yoon, S.-S.
    Park, S.
    Kim, B. K.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S138 - S138
  • [8] Causes of death in patients (pts) with acute myelogenous lukemia (AML) and high-risk myelodysplastic syndrome (MDS) undergoing induction chemotherapy (IC).
    Mattiuzzi, GN
    Alvarado, G
    Alvarez, R
    Pierce, S
    Cortes, J
    Kantarjian, H
    Giles, F
    Faderl, S
    Estey, E
    [J]. BLOOD, 2003, 102 (11) : 878A - 878A
  • [9] Double induction (DI) chemotherapy for patients (pts) with newly diagnosed acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS).
    Garcia-Manero, G
    Faderl, S
    Giles, F
    Verstovsek, S
    Beran, M
    Andreeff, M
    Cortes, J
    Thomas, D
    Koller, C
    Pierce, S
    Ouzonian, S
    Kantarjian, H
    Estey, E
    [J]. BLOOD, 2002, 100 (11) : 342A - 342A
  • [10] Antifungal Prophylaxis (AFP) for Patients (Pts) with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Undergoing Intensive Chemotherapy: An Experience with 730 Pts
    Mattiuzzi, Gloria
    Kantarjian, Hagop
    Ho, Jennifer
    Garcia-Manero, Guillermo
    Cortes, Jorge
    [J]. BLOOD, 2009, 114 (22) : 1206 - 1206
12345